RIGGS RORY B

CIK 00010168352 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001016835

Recent Transactions

21 trades

Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-03-30$36.26/sh−130,024→ 1,456,762 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-03-30$36.26/sh−130,024→ 1,456,762 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-03-29$36.95/sh−9,926→ 1,586,786 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-03-29$36.95/sh−9,926→ 1,586,786 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2022-12-30$52.92/sh+321→ 78,047 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2022-12-30$52.92/sh+321→ 78,047 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2022-12-30$52.92/sh+321→ 78,047 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2022-12-30$52.92/sh+321→ 78,047 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-03-29$38.59/sh−60,000→ 601,712 total
Sale
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2022-03-29$38.59/sh−60,000→ 601,712 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2021-09-30$37.28/sh+422→ 76,515 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2019-06-18+14,189→ 131,297 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2019-06-18−14,189→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2019-06-18+14,189→ 131,297 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2019-06-18−14,189→ 0 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2016-12-30+960→ 32,630 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2016-12-30+960→ 32,630 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2015-12-31$53.79/sh+197→ 15,679 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2015-12-31$53.79/sh+197→ 15,679 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2014-12-31+601→ 14,441 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2014-12-31+601→ 14,441 total

Companies

Recent Filings

Address

C/O INTRA-CELLULAR THERAPIES, INC. 430 EAST 29TH STREET

NEW YORK, NY, 10016

View on SEC.gov